{"id":"https://openalex.org/W4140260","doi":"https://doi.org/10.2165/11319940-000000000-00000","title":"Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and \u03b2-Blockers","display_name":"Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and \u03b2-Blockers","publication_year":2010,"publication_date":"2010-01-28","ids":{"openalex":"https://openalex.org/W4140260","doi":"https://doi.org/10.2165/11319940-000000000-00000","mag":"4140260","pmid":"https://pubmed.ncbi.nlm.nih.gov/20104935"},"language":"en","primary_location":{"id":"doi:10.2165/11319940-000000000-00000","doi":"https://doi.org/10.2165/11319940-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/11319940-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S151621711","display_name":"American Journal of Cardiovascular Drugs","issn_l":"1175-3277","issn":["1175-3277","1179-187X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal Cardiovascular Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101588343","display_name":"Zefeng Zhang","orcid":"https://orcid.org/0009-0003-9635-2691","observed_orcids":["https://orcid.org/0009-0003-9635-2691"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I199305430","display_name":"Nantong University","ror":"https://ror.org/02afcvw97","country_code":"CN","type":"education","lineage":["https://openalex.org/I199305430"]}],"countries":["CN","US"],"is_corresponding":true,"raw_author_name":"Zefeng Zhang","raw_affiliation_strings":["School of Public Health, Nantong University, Nantong, P.R. China. zefengzh@yahoo.com","Emory Program in Cardiovascular Outcomes Research and Epidemiology, Emory University School of Medicine, Atlanta, USA","School of Public Health, Nantong University, Nantong, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Public Health, Nantong University, Nantong, P.R. China. zefengzh@yahoo.com","institution_ids":["https://openalex.org/I199305430"]},{"raw_affiliation_string":"Emory Program in Cardiovascular Outcomes Research and Epidemiology, Emory University School of Medicine, Atlanta, USA","institution_ids":["https://openalex.org/I150468666"]},{"raw_affiliation_string":"School of Public Health, Nantong University, Nantong, P.R. China","institution_ids":["https://openalex.org/I199305430"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074436448","display_name":"Elizabeth M. Mahoney","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth M. Mahoney","raw_affiliation_strings":["Mid America Heart Institute, Kansas City, Missouri, USA","Mid America Heart Institute, Kansas City, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mid America Heart Institute, Kansas City, Missouri, USA","institution_ids":[]},{"raw_affiliation_string":"Mid America Heart Institute, Kansas City, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032478554","display_name":"Paul Kolm","orcid":"https://orcid.org/0000-0003-2653-5452","observed_orcids":["https://orcid.org/0000-0003-2653-5452"]},"institutions":[{"id":"https://openalex.org/I1281704429","display_name":"Christiana Care Health System","ror":"https://ror.org/02h905004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1281704429"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Kolm","raw_affiliation_strings":["Christiana Care Health System, Newark, Delaware, USA","Christiana Care Health System, Newark, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christiana Care Health System, Newark, Delaware, USA","institution_ids":["https://openalex.org/I1281704429"]},{"raw_affiliation_string":"Christiana Care Health System, Newark, USA","institution_ids":["https://openalex.org/I1281704429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015021993","display_name":"John A. Spertus","orcid":"https://orcid.org/0000-0002-2839-2611","observed_orcids":["https://orcid.org/0000-0002-2839-2611"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Spertus","raw_affiliation_strings":["Mid America Heart Institute, Kansas City, Missouri, USA","Mid America Heart Institute, Kansas City, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mid America Heart Institute, Kansas City, Missouri, USA","institution_ids":[]},{"raw_affiliation_string":"Mid America Heart Institute, Kansas City, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016786296","display_name":"J. Jaime","orcid":"https://orcid.org/0000-0001-5470-3754","observed_orcids":["https://orcid.org/0000-0001-5470-3754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaime Caro","raw_affiliation_strings":["Caro Research, Inc., Boston, Massachusetts, USA","Caro Research, Inc., Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Caro Research, Inc., Boston, Massachusetts, USA","institution_ids":[]},{"raw_affiliation_string":"Caro Research, Inc., Boston, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111673053","display_name":"Richard J. Willke","orcid":"https://orcid.org/0000-0001-5649-7771","observed_orcids":["https://orcid.org/0000-0001-5649-7771"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Willke","raw_affiliation_strings":["Pfizer, Inc., New York, New York, USA","Pfizer, Inc., New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, New York, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Pfizer, Inc., New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052993534","display_name":"William S. Weintraub","orcid":"https://orcid.org/0000-0002-5384-5571","observed_orcids":["https://orcid.org/0000-0002-5384-5571"]},"institutions":[{"id":"https://openalex.org/I1281704429","display_name":"Christiana Care Health System","ror":"https://ror.org/02h905004","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1281704429"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William S. Weintraub","raw_affiliation_strings":["Christiana Care Health System, Newark, Delaware, USA","Christiana Care Health System, Newark, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christiana Care Health System, Newark, Delaware, USA","institution_ids":["https://openalex.org/I1281704429"]},{"raw_affiliation_string":"Christiana Care Health System, Newark, USA","institution_ids":["https://openalex.org/I1281704429"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5101588343"],"corresponding_institution_ids":["https://openalex.org/I150468666","https://openalex.org/I199305430"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":4.5085,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.94053352,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"10","issue":"1","first_page":"55","last_page":"63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.5570999979972839,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.5570999979972839,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.3521000146865845,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eplerenone","display_name":"eplerenone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8130000233650208},{"id":"https://openalex.org/keywords/aldosterone-blockade","display_name":"aldosterone blockade","score":0.7129999995231628},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9829999804496765},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9950000047683716},{"id":"https://openalex.org/keywords/ephesus-trial","display_name":"EPHESUS trial","score":0.9380000233650208},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8899999856948853},{"id":"https://openalex.org/keywords/resource-utilization-health-care","display_name":"resource utilization (health care)","score":0.5519999861717224},{"id":"https://openalex.org/keywords/hospitalization-costs","display_name":"hospital costs","score":0.4950000047683716},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.3409999907016754},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.3569999933242798},{"id":"https://openalex.org/keywords/cost-per-life-year-gained","display_name":"cost per life-year gained","score":0.5260000228881836},{"id":"https://openalex.org/keywords/propensity-score-adjustment","display_name":"propensity score adjustment","score":0.40400001406669617},{"id":"https://openalex.org/keywords/net-benefit-regression","display_name":"net-benefit regression","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2780072264","wikidata":"https://www.wikidata.org/wiki/Q423804","display_name":"Eplerenone","level":4,"score":0.9643716812133789},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9297047853469849},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.7265457510948181},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.7040244340896606},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6617311835289001},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6158342361450195},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.5905043482780457},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4712812304496765},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.4319761097431183},{"id":"https://openalex.org/C2776379505","wikidata":"https://www.wikidata.org/wiki/Q422188","display_name":"Spironolactone","level":3,"score":0.3570060133934021},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.19869813323020935},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077545","descriptor_name":"Eplerenone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000451","descriptor_name":"Mineralocorticoid Receptor Antagonists","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000451","descriptor_name":"Mineralocorticoid Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D012044","descriptor_name":"Regression Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013148","descriptor_name":"Spironolactone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013148","descriptor_name":"Spironolactone","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D013148","descriptor_name":"Spironolactone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2165/11319940-000000000-00000","doi":"https://doi.org/10.2165/11319940-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/11319940-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S151621711","display_name":"American Journal of Cardiovascular Drugs","issn_l":"1175-3277","issn":["1175-3277","1179-187X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal Cardiovascular Drugs","raw_type":"journal-article"},{"id":"pmid:20104935","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20104935","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of cardiovascular drugs : drugs, devices, and other interventions","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1496559392","https://openalex.org/W1524311482","https://openalex.org/W1589504844","https://openalex.org/W1994222210","https://openalex.org/W1995479008","https://openalex.org/W2026628004","https://openalex.org/W2031828329","https://openalex.org/W2058058357","https://openalex.org/W2083991584","https://openalex.org/W2115131213","https://openalex.org/W2133739239","https://openalex.org/W2143795636","https://openalex.org/W2152094259","https://openalex.org/W2164269479","https://openalex.org/W2169928187","https://openalex.org/W2270092661","https://openalex.org/W2323458614","https://openalex.org/W2328926651"],"related_works":["https://openalex.org/W2133739239","https://openalex.org/W2020377954","https://openalex.org/W2052973675","https://openalex.org/W2089069235","https://openalex.org/W7027420722","https://openalex.org/W2060596879","https://openalex.org/W1978455790","https://openalex.org/W2905702007","https://openalex.org/W1977193071","https://openalex.org/W2155363096"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}